骨质疏松症健康相关生活质量:QUALEFFO-41测量性能的系统综述
该系统综述检索MEDLINE、EBSCOhost和Cochrane Library至2022年12月,纳入8项研究,按COSMIN指南和改良GRADE评价QUALEFFO-41的测量性能。QUALEFFO-41被归为B类,内容效度有中等质量证据支持,结构效度(假设检验)有中至高质量证据支持,但反应性证据质量极低。
要点
- QUALEFFO-41被归为B类,内容效度有中等质量证据支持其充分性。
- 结构效度(假设检验)有中至高质量证据支持其充分性,但社会功能域聚合效度除外。
- 反应性仅有极低质量证据支持其充分性,测量误差、跨文化效度和效标效度均无研究报告。
核心结论
- QUALEFFO-41可能是一个有前景、有效且可靠的PROM,用于评估伴有椎体骨折的骨质疏松患者的HRQoL。
- 未来研究必须聚焦于良好的方法学质量以强化测量性能证据,尤其是结构效度、信度、反应性和跨文化效度。
研究设计与样本
- 系统检索MEDLINE、EBSCOhost和Cochrane Library自建库至2022年12月的文献。
- 共识别99篇文章,最终纳入8项研究。
- 依据COSMIN指南评价每个测量性能的方法学质量,采用更新版良好测量性能标准评定证据,并用改良GRADE方法分级证据质量。
主要发现
- 内容效度有中等质量证据支持其充分性。
- 结构效度(假设检验)有中至高质量证据支持其充分性,但社会功能域的聚合效度除外。
- 反应性仅有极低质量证据支持其充分性。
- 结构效度和内部一致性仅疼痛域和总体健康感知域有低质量证据支持其充分性。
- 信度仅躯体功能域有低质量证据支持其充分性。
关键数值与推荐
- QUALEFFO-41被归为B类。
- 无研究报告测量误差、跨文化效度和效标效度。
临床怎么用
- 原文未据此给出推荐。
局限性
- 反应性仅有极低质量证据支持其充分性。
- 结构效度和内部一致性仅疼痛域和总体健康感知域有低质量证据支持其充分性。
- 信度仅躯体功能域有低质量证据支持其充分性。
- 无研究报告测量误差、跨文化效度和效标效度。
- 未来研究必须聚焦于良好的方法学质量以强化测量性能证据,尤其是结构效度、信度、反应性和跨文化效度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The 41-item Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO-41) is a widely used and freely available patient-reported outcome measure (PROM). However, data on its reliability, validity, and responsiveness remain unclear. Therefore, this study aimed to systematically review the measurement properties of the QUALEFFO-41. A systematic search of MEDLINE, EBSCOhost, and Cochrane Library from their inception up to December 2022 was performed. Data were extracted, and the methodological quality of each measurement property was evaluated according to the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) guidelines. The evidence of the measurement properties was rated against the updated criteria for good measurement properties, and the quality of evidence was graded using the modified GRADE approach. A total of 99 articles were identified, of which eight studies were included in the review. The QUALEFFO-41 is categorized as B as it demonstrated moderate quality evidence for sufficient content validity, moderate-to-high quality evidence for sufficient hypothesis testing for construct validity (except for the social function domain for convergent validity), and very low-quality evidence for sufficient responsiveness. For structural validity and internal consistency, only the domains of pain and general health perception were sufficient with low-quality evidence. For reliability, only the domain of physical function was sufficient with low-quality evidence. None of the studies reported measurement error, cross-cultural validity, and criterion validity. The QUALEFFO-41 may be a promising, valid, and reliable PROM to assess HRQoL in osteoporosis patients with vertebral fractures. However, future studies must focus on good methodological quality to strengthen the evidence of measurement properties, especially on structural validity, reliability, responsiveness, and cross-cultural validity. The systematic review evaluated the measurement properties of the QUALEFFO-41 questionnaire for assessing Health-Related Quality of Life (HRQoL) in osteoporosis patients. The review found moderate-to-high-quality evidence for construct validity but limited evidence for responsiveness and other properties. Future studies should focus on strengthening the evidence, particularly for structural validity, reliability, responsiveness, and cross-cultural validity. The QUALEFFO-41 shows promise as a valid and reliable PROM for HRQoL assessment in osteoporosis patients.
引用
- Choo YW, Mohd Tahir NA, Mohamed Said MS, et al. Health-related quality of life in osteoporosis: a systematic review of measurement properties of the QUALEFFO-41. Osteoporos Int. 2024. PMID: 38194151. doi:10.1007/s00198-023-07005-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。